Renal Complications of Intravenous Drug Abuse and Human Immunodeficiency Virus Infection

  • Jacques J. Bourgoignie


In the 1970s, the nephropathology of drug addiction was dominated by diseases related to the use of heroin. In the 1980s, nephropathies related to infection with the human immunodeficiency virus (HIV) emerged, and the relative incidence of these two types of nephropathies sharing intravenous drug use as a risk factor completely changed. Heroin-associated nephropathy essentially disappeared. In fact, the author has not seen a single example of heroin-associated nephropathy (HAN) at the University of Miami/Jackson Memorial Medical Center since 1985. On the other hand, nephropathies related to HIV infection have become an important problem in large medical centers. We, therefore, will provide only an outline of intravenous (I.V.) drug abuse-related nephropathies to remind the reader of the various types of renal diseases that can occur with drug addiction and concentrate on the renal complications associated with HIV infection.


Human Immunodeficiency Virus Nephrotic Syndrome Human Immunodeficiency Virus Infection Hemolytic Uremic Syndrome Thrombotic Thrombocytopenic Purpura 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lombard J, Wong B, Young JH: Acute renal failure due to rhabdomyolysis associated with cocaine toxicity. West J Med 148: 466–468, 1988.PubMedGoogle Scholar
  2. 2.
    Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ: Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 319: 673–677, 1988.PubMedCrossRefGoogle Scholar
  3. 3.
    Anand V, Siami O, Stone WJ: Cocaine-associated rhabdomyolysis and acute renal failure. South Med J 82: 6769, 1989.CrossRefGoogle Scholar
  4. 4.
    Pogue VA, Nurse HM: Cocaine-associated acute myoglobinuric renal failure. Am J Med 86: 183–186, 1989.PubMedCrossRefGoogle Scholar
  5. 5.
    Singhal P, Horowitz B, Quinones MC, Sommer M, Faulkner M, Grosser M: Acute renal failure following cocaine abuse. Nephron 52: 76–78, 1989.PubMedCrossRefGoogle Scholar
  6. 6.
    Nolte KB: Rhabdomyolysis associated with cocaine abuse. Hum Pathol 22: 1141–1145, 1991.PubMedCrossRefGoogle Scholar
  7. 7.
    Mittleman RE, Wetli CV: The pathology of cocaine abuse. Adv Pathol Lab Med 4: 37–73, 1991.Google Scholar
  8. 8.
    Sheref JA: Renal infarction associated with intravenous cocaine use. Ann Emerg Med 13: 1145–1147, 1984.CrossRefGoogle Scholar
  9. 9.
    Wohlman RA: Renal artery thrombosis and embolization associated with intravenous cocaine injection. South Med J 80: 928–930, 1987.PubMedCrossRefGoogle Scholar
  10. 10.
    Chavez GF, Mulinare J, Cordero JF: Maternal cocaine use during early pregnancy as a risk factor for congenital uro-genital anomalies, 1989.Google Scholar
  11. 11.
    Chasnoff IJ, Chisum GM, Kaplan WE: Maternal cocaine use and genitourinary malformations. Teratology 37: 201–204, 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Sapira JD: The narcotic addict as a medical patient. Am J Med 45: 555–588, 1968.PubMedCrossRefGoogle Scholar
  13. 13.
    Menda KB, Gorbach SL: Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med 78: 25–32, 1973.PubMedCrossRefGoogle Scholar
  14. 14.
    Sklaver AR, Hoffman TA, Greenman RL: Staphylococcal endocarditis in addicts. South Med J 71: 638–643, 1978.PubMedCrossRefGoogle Scholar
  15. 15.
    Sande MA, Lee BL, Mills J, Chambers III HF: Endocarditis in intravenous drug users. In: D Kaye, ed, Infective Endocarditis, 2nd ed. Raven Press, Baltimore, pp 345–359, 1992.Google Scholar
  16. 16.
    Tuazon CU, Sheagren JN: Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 82: 788–790, 1975.PubMedCrossRefGoogle Scholar
  17. 17.
    Kilcoyne MM, Daly JJ, Gocke DJ, Thompson GE, Meltzer JI, Hsu KC, Tannenbaum M: Nephrotic syndrome in heroin addicts. Lancet 1: 17–20, 1972.PubMedCrossRefGoogle Scholar
  18. 18.
    Rao TKS, Nicastri AD, Friedman EA: Natural history of heroin associated nephropathy. N Engl J Med 290: 19–23, 1974.PubMedCrossRefGoogle Scholar
  19. 19.
    Grishman E, Churg J, Porush JG: Glomerular morphology in nephrotic heroin addicts. Lab Invest 35: 415–424, 1976.PubMedGoogle Scholar
  20. 20.
    Rao TKS, Nicastri AD, Friedman EA: Renal consequences of narcotic abuse. Adv Nephrol 7: 261–290, 1977.Google Scholar
  21. 21.
    Llach F, Descoeudres C, Massry SG: Heroin associated nephropathy: clinical and histological studies in 19 patients. Clin Nephrol 11: 7–12, 1979.PubMedGoogle Scholar
  22. 22.
    Treser G, Cherubin C, Lonergar ET, Joshizawa N, Viswanathan V, Tannenberg AM, Pompa D, Lange K: Renal lesions in narcotic addicts. Am J Med 57: 687–694, 1974.PubMedCrossRefGoogle Scholar
  23. 23.
    Cunningham EE, Venuto RC, Zielezny MA: Adulterants in heroin/cocaine: implications concerning heroin-associated nephropathy. Drug Alcohol Depend 14: 19–22, 1984.PubMedCrossRefGoogle Scholar
  24. 24.
    May DC, Helderman JH, Eigenbrodt EH, Silva FG: Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T’s and blues abusers. Am J Kidney Dis 8: 404409, 1986.Google Scholar
  25. 25.
    Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC: Heroin nephropathy: a clinicopathologic and epidemiologic study. Am J Med 68: 47–53, 1980.PubMedCrossRefGoogle Scholar
  26. 26.
    Cunningham EE, Zielezny MA, Venuto RC: Heroin-associated nephropathy: a nationwide problem. JAMA 250: 2935–2936, 1983.PubMedCrossRefGoogle Scholar
  27. 27.
    Friedman EA, Rao TKS: Why does uremia in heroin abusers occur predominantly in Blacks? (editorial). JAMA 250: 2965 2966, 1983.Google Scholar
  28. 28.
    Haskell LP, Glicklich D, Senitzer D: HLA associations in heroin-associated nephropathy. Am J Kidney Dis 12: 45–50, 1988.PubMedGoogle Scholar
  29. 29.
    Rao TKS, Nicastri AD, Friedman EA: The nephropathies of drug addiction and acquired immune deficiency syndrome. In: CG Tischer, BM Brenner, eds, Renal Pathology, 1st ed, vol 1. JB Lippincott, Philadelphia, pp 340–356, 1989.Google Scholar
  30. 30.
    Menchel S, Cohen D, Gross E, Frangione B, Gallo G: AA protein-related renal amyloidosis in drug addicts. Am J Pathol 112: 195–199, 1983.PubMedGoogle Scholar
  31. 31.
    Dubrow A, Mittman N, Ghali V, Flamenbaum W: The changing spectrum of heroin-associated nephropathy. Am J Kidney Dis 5: 36–41, 1986.Google Scholar
  32. 32.
    Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS: Amyloidosis in subcutaneous heroin users (“skin-poppers’ amyloid”). Am J Med 81: 635–640, 1986.PubMedCrossRefGoogle Scholar
  33. 33.
    Chan YF, Wong PK, Chow TC: Acute myoglobinuria as a fatal complication of heroin addiction. Am J Forensic Med Pathol 11: 160–164, 1990.PubMedCrossRefGoogle Scholar
  34. 34.
    Kringsholm B, Christoffersen P: The nature and occurrence of birefringent material in different organs in fatal drug addiction. Forensic Sci Int 34: 53–62, 1987.PubMedCrossRefGoogle Scholar
  35. 35.
    Riddick L: Disseminated granulomatosis through a patent foramen ovale in an intravenous drug user with pulmonary hypertension. Am J Forensic Med Pathol 8: 326–333, 1987.PubMedCrossRefGoogle Scholar
  36. 36.
    Cacoub P, Lunel Fabiani F, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P: Mixed cryoglobulinemia and hepatitis C. Am J Med 96: 124–132, 1994.PubMedCrossRefGoogle Scholar
  37. 37.
    Chattha G, Arieff AI, Cummings C, Tierney LM Jr: Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 118: 37–39, 1993.PubMedCrossRefGoogle Scholar
  38. 38.
    Seney FD Jr, Burns DK, Silva FG: Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 16: 1–13, 1990.PubMedGoogle Scholar
  39. 39.
    Vitting KE, Gardenswartz MH, Zabetakis PM, Tapper ML, Gleim GW, Agarwal MK, Robinson AG, Michelis MF: Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 263: 973–976, 1990.PubMedCrossRefGoogle Scholar
  40. 40.
    Agarwal A, Soni A, Ciechanowsky M, Chander P, Treser G: Hyponatremia in patients with the acquired immunodeficiency syndrome. Nephron 53: 317–321, 1989.PubMedCrossRefGoogle Scholar
  41. 41.
    Greene LW, Cole W, Greene JB, Levy B, Louie E, Raphael B, Waitkevicz HJ, Blum M: Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med 101: 497–498, 1984.PubMedCrossRefGoogle Scholar
  42. 42.
    Kahn G, Torensky L, Seras DS, Zumoff B: Hyporeninemic hypoaldosteronism associated with the acquired immunodeficiency syndrome. Am J Med 82: 1035–1038, 1987.CrossRefGoogle Scholar
  43. 43.
    Guenthner EE, Rabinowe SL, Van Niel A, Naftilan A, Dluhy RG: Primary Addison’s disease in a patient with the acquired immunodeficiency syndrome. Ann Intern Med 100: 847–848, 1984.PubMedCrossRefGoogle Scholar
  44. 44.
    Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E: Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 65: 482–487, 1987.PubMedCrossRefGoogle Scholar
  45. 45.
    Biglieri EG: Adrenocortical function in the acquired immunodeficiency syndrome (AIDS). WestJ Med 148: 70–73, 1988.Google Scholar
  46. 46.
    Glasgow BJ, Steinsapir KD, Anders K, Layfield U: Adrenal pathology in the acquired immunodeficiency syndrome. Am J Clin Pathol 84: 594–597, 1985.PubMedGoogle Scholar
  47. 47.
    Santos GI, Garcia PI, del Arco GC, Martinez Garcia MC, Noguerado Asensio A: Sindrome de secrecion inapropiada asociado con el sindrome de immunodeficiencia adquirida. Rev Clin Esp 188: 120–122, 1991.Google Scholar
  48. 48.
    Tang WW, Feinstein EI, Massry SG: Hyponatremia in patients with acquired immune deficiency syndrome and the AIDS related complex (abstract). Kidney Int 33: 211, 1988.Google Scholar
  49. 49.
    Farese RV Jr, Schambelan M, Hollander H, Stringari S, Jacobson MA: Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Ann Intern Med 112: 955–956, 1990.PubMedCrossRefGoogle Scholar
  50. 50.
    Peter SA: Electrolyte disorders and renal dysfunction in acquired immunodeficiency syndrome patients. J Natl Med Assoc 83: 889–891, 1991.PubMedGoogle Scholar
  51. 51.
    Briceland LL, Bailie GR: Pentamidine-associated nephrotoxicity and hyperkalemia in patients with AIDS. Drug Intell Clin Pharm 25: 1171–1174, 1991.Google Scholar
  52. 52.
    Lachaal M, Venuto RC: Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 87: 260–263, 1989.PubMedCrossRefGoogle Scholar
  53. 53.
    Greenberg S, Reiser IW, Chou S, Porush J: Trimethroprimsulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 119: 291–295, 1993.PubMedCrossRefGoogle Scholar
  54. 54.
    Velasquez H, Perazella MA, Wright FS, Ellison DH: Renal mechanism of trimethroprim-induced hyperkalemia. Ann Intern Med 119: 296–301, 1993.CrossRefGoogle Scholar
  55. 55.
    Shah GM, Alvarado P, Kirschenbaum MA: Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med 89: 380–382, 1990.PubMedCrossRefGoogle Scholar
  56. 56.
    Mani S: Pentamidine induced renal magnesium wasting (letter). AIDS 6: 594–595, 1992.PubMedCrossRefGoogle Scholar
  57. 57.
    Berns JS, Cohen RM, Stumacher RJ, Rudnick MR: Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections. J Am Soc Nephrol 1: 1061–1080, 1991.PubMedGoogle Scholar
  58. 58.
    Jacobs MB: The acquired immunodeficiency syndrome and hypercalcemia. Western J Med 144: 469–471, 1986.Google Scholar
  59. 59.
    Cockerell CJ, Dolan ET: Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. J Am Acad Dermatol 26: 559–562, 1992.PubMedCrossRefGoogle Scholar
  60. 60.
    Maesaka JK, Cusano AJ, Thies HL, Siegal FP, Dreisbach AW: Hypouricemia in acquired immunodeficiency syndrome. Am J Kidney Dis 15: 252–257, 1990.PubMedGoogle Scholar
  61. 61.
    Chen JL, Brocavich JM, Lin AY: Psychiatric disturbances associated with ganciclovir therapy. Ann Pharmacother 26: 193–195, 1992.PubMedGoogle Scholar
  62. 62.
    Valeri A, Neusy AJ: Acute and chronic renal disease in hospitalized AIDS patients. Clin Nephrol 35: 110–118, 1991.PubMedGoogle Scholar
  63. 63.
    Genderini A, Bertoli S, Scorza D, Landriani N, Barone MT, Barbiano di Belgiojoso G: Acute renal failure in patients with acquired immune deficiency syndrome. J Nephrol 1: 4547, 1991.Google Scholar
  64. 64.
    Cantor ES, Kimmel PL, Bosch JP: Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151: 125–128, 1991.PubMedCrossRefGoogle Scholar
  65. 65.
    Rao TK, Friedman EA: Renal syndromes in the acquired immunodeficiency syndrome (AIDS): lessons learned from analysis over 5 years. Artif Organs 12: 206–209, 1988.PubMedCrossRefGoogle Scholar
  66. 66.
    Bourgoignie JJ: Renal complications of human immunodeficiency virus type 1. Kidney Int 37: 1571–1584, 1990.PubMedCrossRefGoogle Scholar
  67. 67.
    Comtois R, Pouliot J, Vinet B, Gervois A, Lemieux G: Higher pentamidine levels in AIDS patients with hypoglycemia and azotemia during treatment of Pneumocystis carinii pneumonia. Am Rev Respir Dis 146: 740–744, 1992.PubMedCrossRefGoogle Scholar
  68. 68.
    Becker BN, Fall P, Hall C, Milam D, Leonard J, Glick A, Schulman G: Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature. Am J Kidney Dis 22: 611–615, 1993.PubMedGoogle Scholar
  69. 69.
    D’Agati V, Cheng JI, Carbone L, Cheng JT, Appel G: The pathology of HIV-nephropathy: a detailed morphologic and comparative study. Kidney Int 35: 1358–1370, 1989.PubMedCrossRefGoogle Scholar
  70. 70.
    Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V: The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis 12: 131–137, 1988.PubMedGoogle Scholar
  71. 71.
    Rashed A, Azadeh B, Abu Romeh SH: Acyclovir-induced acute tubulo-interstitial nephritis. Nephron 56: 436–438, 1990.PubMedCrossRefGoogle Scholar
  72. 72.
    Raisin J, Hess B, Blatter M, Zimmerman A, Descoeudres C, Horber FF, Jaeger P: Toxicity of an organic germanium compound: deleterious consequences of a “natural remedy.” Schweiz Med Wochenschr 122: 11–13, 1992.PubMedGoogle Scholar
  73. 73.
    Christin S, Baumelou A, Bahri S, Ben Hmida M, Deray G, Jacobs C: Acute renal failure due to sulfadiazine in patients with AIDS. Nephron 55: 233–234, 1990.PubMedCrossRefGoogle Scholar
  74. 74.
    Carbone LG, Bendixen B, Appel GB: Sulfadiazineassociated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. Am J Kidney Dis 12: 72–75, 1988.PubMedGoogle Scholar
  75. 75.
    Molina JM, Belenfant X, Doco-Lecompte T, Idatte JM, Modai J: Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. Aids 5: 587–589, 1991.PubMedCrossRefGoogle Scholar
  76. 76.
    Sawyer MH, Webb DE, Balow JE, Strauss SE: Acyclovirinduced acute renal failure. Clinical course and histology. Am J Med 84: 1067–1071, 1988.PubMedCrossRefGoogle Scholar
  77. 77.
    Ogea Garcia JL, Villanueva Marcos JL, Jurado R, Rivero S: Linfoma de Burkitt y AIDS presentacion como hepatomegalia tumoral e insuficiencia renal aguda debida a depositos de uratos (letter). Anales Med Int 6: 551–552, 1989.Google Scholar
  78. 78.
    Mohler JL, Jarow JP, Marshall FF: Unusual urological presentations of acquired immune deficiency syndrome: large cell lymphoma. J Urol 138: 627–629, 1989.Google Scholar
  79. 79.
    Spector DA, Katz RS, Fuller H, Cristiano LM, Vitalis S, Jarrow J: Acute non-dilating obstructive renal failure in a patient with AIDS. Am J Nephrol 9: 129–132, 1989.PubMedCrossRefGoogle Scholar
  80. 80.
    Comiter S, Glasser J, Al-Askari S: Ureteral obstruction in a patient with Burkitt’s lymphoma. Urology 39: 277–289, 1992.PubMedCrossRefGoogle Scholar
  81. 81.
    Navarro JF, Liano F, Garcia Larana J, Garcia Gonzalez R, Pasmal J, Ortuno J: Lymphomatous infiltration of the kidneys as presentation of acquired immunodeficiency syndrome. Nephrol Dial Transplant 9: 175–177, 1994.PubMedGoogle Scholar
  82. 82.
    Jokela J, Flynn T, Henry K: Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)seropositive homosexual man. Am J Hematol 25: 341–343, 1987.PubMedCrossRefGoogle Scholar
  83. 83.
    Nair JMG, Bellevue R, Bertoni M, Dosik H: Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex: a report of 2 cases. Ann Intern Med 109: 209–212, 1988.PubMedCrossRefGoogle Scholar
  84. 84.
    Platanias NC, Paiusco D, Bernstein S, Murali MR: Thrombotic thrombocytopenic purpura as the first manifestation of human immunodeficiency virus infection. Am J Med 87: 699–700, 1989.PubMedCrossRefGoogle Scholar
  85. 85.
    Leaf AN, Laubenstein LJ, Raphael B, Hoschster H, Baez J, Karpatkin S: Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 infection. Ann Intern Med 109: 194–197, 1988.PubMedCrossRefGoogle Scholar
  86. 86.
    Charasse C, Michelet C, Le Tulzo Y, Liegaux JM, Camus C, Thomas R, Cartier F, Ramee MP: Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome: a pathologically documented case report. Am J Kidney Dis 17: 80–82, 1991.PubMedGoogle Scholar
  87. 87.
    Boccia RV, Gelmann EP, Baker CC, Marti G, Longo DL: A hemolytic uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med 101: 716–717, 1984.PubMedCrossRefGoogle Scholar
  88. 88.
    Esforzado N, Poch E, Almirall J, Lopez-Pedret J, Revert L: Hemolytic uremic syndrome associated with HIV infection (letter). AIDS 5: 1041–1042, 1991.PubMedCrossRefGoogle Scholar
  89. 89.
    Segal GH, Tubbs RR, Ratliff NB, Miller ML, Longworth DL: Thrombotic thrombocytopenic purpura in a patient with AIDS. Cleveland Clin J Med 57: 360–366, 1990.CrossRefGoogle Scholar
  90. 90.
    Meisenberg BR, Robinson WL, Mosley CA, Duke MS, Rabetoy GM, Kosty MP: Thrombotic thrombocytopenic purpura in human immunodeficiency (HIV) seropositive males. Am J Hematol 27: 212–215, 1988.PubMedCrossRefGoogle Scholar
  91. 91.
    Mittelman A, Bertram J, Henry DH, Snyder HW Jr, Messerschmidt GL, Ciavarella D, Ainsworth S, Kiprov D, Arlin Z: Treatment of patients with HIV thrombocytopenia and hemolytic uremic syndrome with protein A (Prosorbacolumn) immunoabsorption. Semin Hematol 26: 15–18, 1989.PubMedGoogle Scholar
  92. 92.
    Frem GJ, Rennke HG, Sayegh MH: Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathy. J Am Soc Nephrol 4: 1643–1648, 1994.PubMedGoogle Scholar
  93. 93.
    Hoepelman AIM, Van Buren M, Van den Broek J, Borleffs JCC: Bacteriuria in men infected with HIV-1 is re lated to their immune status (CD4 cell count). AIDS 6: 179 189, 1992.Google Scholar
  94. 94.
    Santos OR, Lopes GS: Renal complications of AIDS: A Latin American perspective. Kidney: Curr Sury World Lit 3: 63–70, 1994.Google Scholar
  95. 95.
    Grateau G, Soffer M, Fritz P, Bonnin A, Sereni D, CremerGA: Guerison par drainage externe d’un abcés périrénal au cours du SIDA. Ann Med Interne (Paris) 139: 403–404, 1988.Google Scholar
  96. 96.
    Gelabert Mas A, Arango O, Bielsa O, Lladó C: Drenaje percutaneo de los abscesos renales y perinefriticos. Actas Urol Esp 16: 513–516, 1992.Google Scholar
  97. 97.
    Valle Gerhold J, Monzón Alebesque F, Lopez Lopez JA: Tratamiento percutaneo de absceso renal micótico por As pergillus fumigatus en un paciente con SIDA. Actas Urol Esp 16: 492–494, 1992.Google Scholar
  98. 98.
    Nadasdy T, Miller KW, Johnson LD, Hanson-Painton O, DeBault LE, Burns KD, Hawkins E, Silva FG: Is cytomega lovirus associated with renal disease in AIDS patients? Mod Pathol 5: 277–282, 1992.Google Scholar
  99. 99.
    Falkoff GE, Rigsby CM, Rosenfield AT: Partial, combined cortical and medullary nephrocalcinosis: US and CT patterns in AIDS-associated MAI infection. Radiology 162: 343–344, 1987.PubMedGoogle Scholar
  100. 100.
    Bargman JM, Wagner C, Cameron R: Renal cortical nephrocalcinosis: a manifestation of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome. Am J Kidney Dis 17: 712–715, 1991.PubMedGoogle Scholar
  101. 101.
    Feuerstein IM, Francis P, Raffeld M, Pluda J: Widespread visceral calcifications in disseminated Pneumocystis carinii infection: CT characteristics. J Comput Assist Tomogr 14: 149–51, 1990.PubMedCrossRefGoogle Scholar
  102. 102.
    Radin DR, Baker EL, Klatt EC, Balthazar EJ, Jeffrey RB Jr,Megibow AJ, Rails PW: Visceral and nodal calcification in patients with AIDS-related Pneumocystis carinii infection. Am J Roentg 154: 27–31, 1990.CrossRefGoogle Scholar
  103. 103.
    Ravalli S, Garcia RL, Vincent RA, Shein R: Disseminated Pneumocystis carinii infection in the acquired immuno deficiency syndrome. NY State J Med 90: 155–157, 1990.Google Scholar
  104. 104.
    Montserrat V, Muntaner L, Muse A, Serra E, Conte A, Torroella V, Gutierrez C, Ozanes M: Urologie neoplasms in AIDS. Actas Urol Esp 16: 35–38, 1992.PubMedGoogle Scholar
  105. 105.
    Bourgoignie JJ, Ortiz-Butcher C, Green DF, Pardo V: Renal disease and AIDS. In: S Broder, TC Merrigan, D Bolognesi, eds, Textbook of AIDS Medicine. Williams and Wilkins, Bal- timore, pp 597–608, 1994.Google Scholar
  106. 106.
    Mazbar SA, Schoenfeld PY, Humphreys MH: Renal involvement in patients infected with HIV: experience at San Francisco General Hospital. Kidney Int 37: 1325–1332, 1990.PubMedCrossRefGoogle Scholar
  107. 107.
    Brunkhorst R, Brunkhorst U, Eisenbach GM, Schedel I, Deicher H: Lack of clinical evidence for a specific HIV- associated glomerulopathy in 203 patients with HIV infec tion. Nephrol Dial Transplant 7: 87–92, 1992.PubMedGoogle Scholar
  108. 108.
    Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669–673, 1984.PubMedCrossRefGoogle Scholar
  109. 109.
    Gardenswartz MH, Lerner CW, Seligson GR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS: Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 21: 197–204, 1984.Google Scholar
  110. 110.
    Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the acquired immunodeficiency syndrome. Ann I tern Med 101: 429–434, 1984.Google Scholar
  111. 111.
    Glassock RJ, Cohen AH, Danovitch G, Parsa KP: Human immunodeficiency virus (HIV) infection and the kidney. Ann Intern Med 112: 35–49, 1990.CrossRefGoogle Scholar
  112. Pardo V, Meneses R, Ossa L, Jaffe DJ, Strauss J, Roth D, Bourgoignie JJ: AIDS-related glomerulopathy: occurence in specific risk groups. Kidney Int 31: 1167–1173, 1989.Google Scholar
  113. 113.
    Cohen AH, Nast CC: HIV-associated nephropathy: a unique combined glomerular, tubular and interstitial lesion. Mod Pathol 1: 87–97, 1988.Google Scholar
  114. 114.
    Soni A, Agarwal A, Chander P, Yoo J, Singal D, Salomon N, Robinson B, Treser G: Evidence for an HIV-related nephropathy: a clinicopathological study. Clin Nephrol 31: 12–17, 1989.PubMedGoogle Scholar
  115. 115.
    Bourgoignie JJ, Ortiz-Interian C, Green DF, Jaffe D, Roth D, Pardo V: The epidemiology of human immunodeficiency virus-associated nephropathy. In: M Hatano, ed, Nephrology, vol 1. Springer Verlag, Tokyo, pp 484–492, 1991.Google Scholar
  116. 116.
    Humphreys MH: Human immunodeficiency virus-associated nephropathy. East is East and West is West? Arch Intern Med 150: 253–255, 1990.Google Scholar
  117. 117.
    Bourgoignie JJ, Ortiz-Interian C, Green DF, Roth D: Race, a co-factor in HIV-1 associated nephropathy. Transplant Proc 21: 3899–3901, 1989.PubMedGoogle Scholar
  118. 118.
    Bourgoignie JJ, Pardo V: The nephropathology in human immunodeficiency virus (HIV-1) infection. Kidney Int 35: S19 - S23, 1991.Google Scholar
  119. 119.
    Stone HD, Appel RG: Human immunodeficiency virusassociated nephropathy: current concepts. Am J Med Sci 307: 212–217, 1994.PubMedCrossRefGoogle Scholar
  120. 120.
    Frassetto L, Schoenfeld PY, Humphreys MH: Increasing incidence of human immunodeficiency virus-associated nephropathy at San Francisco General Hospital. Am J Kidney Dis 18: 655–659, 1991.PubMedGoogle Scholar
  121. 121.
    Lopes GS, Marques LPJ, Rioja LS, Basilio-de-Oliveira C, Oliveira AV, Nery ACF, Santos OR: Glomerular disease and human immunodeficiency virus infection in Brazil. Am J Nephrol 12: 281–287, 1992.Google Scholar
  122. 122.
    Nochy D, Gotz D, Dosquet P, Pruna A, Guettier C, Weiss L, Hinglais N, Idatte JM, Mery JP, Kazatchkine M, Druet P, Bariety J: Renal disease associated with HIV infection. A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8: 11, 1993.PubMedGoogle Scholar
  123. 123.
    van der Reijden HJ, Schipper MEF, Danner SA, Arisz L: Glomerular lesions and opportunistic infections of the kidney in AIDS: an autopsy study of 47 cases. Adv Exp Med Biol252: 181–189, 1989.Google Scholar
  124. 124.
    Michel C, Dosquet P, Ronco P, Mougenot B, Viron B, Mignon F: Nephropathy associated with human immunodeficiency virus: a report of 11 cases including 6 treated with zidovudine. Nephron 62: 441, 1992.CrossRefGoogle Scholar
  125. 125.
    Esforzado N, Feliz T, Almirall J, Torras A, Miro JM, Gatell JM, Regert L: Nephropathy in human immunodeficiency virus infection. Med Clin (Barcelona) 98: 764–767, 1992.Google Scholar
  126. 126.
    Pakasa M, Mangani N, Dikassa L: Focal and segmental glomerulosclerosis in nephrotic syndrome: a new profile of adult nephrotic syndrome in Zaire. Mod Pathol 6: 125–128, 1993.PubMedGoogle Scholar
  127. 127.
    Bourgoignie JJ: Glomerulosclerosis associated with human immunodeficiency virus infection. In: P Kimmel, J Stein, eds, Contemporary Issues in Nephrology. Churchill Livingstone, New York, 29:59–75, 1996.Google Scholar
  128. 128.
    Kimmel PL, Phillips TM, Farkas-Szallasi T, Ferreira-Centeno A, Abraham AA, Garrett CT: Idiotypic IgA nephropathy in patients with HIV infection N Engl J Med 327: 702–706, 1992.PubMedCrossRefGoogle Scholar
  129. 129.
    Kimmel PL, Phillips TM, Ferreira-Centeno A, FarkasSzallasi T, Abraham AA, Garrett CT: HIV-associated immune-mediated renal disease. Kidney Int 44: 1022–1029, 1993.PubMedCrossRefGoogle Scholar
  130. 130.
    Korbet SM, Schwartz MM: Renal biopsy conference from the Rush-Presbyterian St. Luke’s Medical Center: human immunodeficiency virus infection and nephrotic syndrome. Am J Kidney Dis 20: 97–103, 1992.PubMedGoogle Scholar
  131. 131.
    Ortiz-Butcher C: The spectrum of kidney diseases in patients with human immunodeficiency virus infection. Curr Opin Nephrol Hypertens 2: 355–364, 1993.PubMedCrossRefGoogle Scholar
  132. 132.
    Hamper UM, Goldblum LE, Hutchins GM, Sheth S, Dahnert WF, Bartlett JG, Sanders RC: Renal involvement in AIDS: sonographic pathologic correlation. Am J Roentg 150: 1321–1325, 1988.CrossRefGoogle Scholar
  133. 133.
    Schaffer RM, Schwartz GE, Becker JA, Rao TK, Shih YH: Renal ultrasound in acquired immune deficiency syndrome. Radiology 153: 511–513, 1984.PubMedGoogle Scholar
  134. 134.
    Kay CJ: Renal disease in patients with AIDS: sonographic findings. Am J Roentg 159: 551–554, 1992.CrossRefGoogle Scholar
  135. 135.
    Baumelou A, Assogba V, Beaufils H, Hinglais W, Ben Hmida M, Christin S, Eugene M, Deray G, Jacobs C: Pathologie rénale associée à l’infection à virus VIH et au syndrome d’immunodéficience acquise. In: C Chatelain, C Jacobs, eds, Sémin Uro-Néphrologie. Masson, Paris, pp 4249, 1989.Google Scholar
  136. 136.
    Cozzi PJ, Abu-Jawdah GM, Green RM, Green D: Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis 14: 189–191, 1992.PubMedCrossRefGoogle Scholar
  137. 137.
    Langs C, Gallo GR, Schacht RG, Sidhu G, Baldwin DS: Rapid renal failure in AIDS-associated focal glomerulosclerosis. Arch Intern Med 150: 287 292, 1990.Google Scholar
  138. 138.
    Carbone L, D’Agati V, Cheng JT, Appel GB: Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87: 389–395, 1989.PubMedCrossRefGoogle Scholar
  139. 139.
    Pardo V, Wetli, Strauss J, Bourgoignie JJ: The renal complications of drug abuse and human immunodeficiency virus. In: C Tischer, BM Brenner, eds, Renal pathology: with Clinical and Functional Correlations. JB Lippincott, Philadelphia, pp 390–418, 1994.Google Scholar
  140. 140.
    Chander P, Soni A, Bhagwat R, Suri A, Yoo J, Treser G: Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 126: 513–526, 1987.PubMedGoogle Scholar
  141. 141.
    Alpers CE, Harawi S, Rennke HG: Focal glomerulosclerosis with tubuloreticular inclusions: possible predictive value for acquired immunodeficiency syndrome (AIDS). Am J Kidney Dis 12: 240–242, 1988.PubMedGoogle Scholar
  142. 142.
    Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416–1424, 1994.PubMedCrossRefGoogle Scholar
  143. 143.
    Rao TK, Friedman EA: AIDS (HIV)-associated nephropathy; does it exist? An in-depth review. Am J Nephrol 9: 441–453, 1989.PubMedCrossRefGoogle Scholar
  144. 144.
    Briner V, Zimmerli W, Cathomas G, Landmann J, Thiel G: HIV-Infektion durch das Nieren transplantant: Fallbeschreibung and Ubersicht über 18 publizierte Fälle. Schweiz Med Wochenschr 119: 1046–1052, 1989.PubMedGoogle Scholar
  145. 145.
    Karlsson-Parra A, Dimeny E, Fellstrom B, Klareskog L: HIV receptors (CD4 antigen) in normal human glomerular cells (letter). N Engl J Med 320: 741, 1989.PubMedGoogle Scholar
  146. 146.
    Alpers CE, McClure J, Bursten SL: Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am J Kidney Dis 19: 126–130, 1992.PubMedGoogle Scholar
  147. 147.
    Cohen AH, Sun NCJ, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2: 125–128, 1989.PubMedGoogle Scholar
  148. 148.
    Barbiano di Belgiojoso G, Genderini A, Vago L, Parravicini C, Bertoli S, Landriani N: Absence of HIV antigens in renal tissue from patients with HIV-associated nephropathy. Nephrol Dial Transplant 5: 489–492, 1990.CrossRefGoogle Scholar
  149. 149.
    Pardo V, Shapshak P, Yoshioka M, Strauss J: HIV associated nephropathy (HIVN). Direct renal invasion or indirect glomerular involvement (abstract). FASEB J 5: 907A, 1991.Google Scholar
  150. 150.
    Nadasdy T, Hanson-Painton O, Davis L, Miller K, Debault L, Burns D, Silva F: Conditions affecting detection of HIV in formalin fixed paraffin embedded sections in kidneys and organs from AIDS patients (abstract). Lab Invest 64: 98A, 1991.Google Scholar
  151. 151.
    Green DR, Resnick L, Bourgoignie JJ: HIV infects glomerular endothelial and mesangial cells but not epithelial cells in vitro. Kidney Int 41: 956–960, 1992.PubMedCrossRefGoogle Scholar
  152. 152.
    Erice A, Kim Y: In-vitro infection of human renal cells by human immunodeficiency virus; pathogenic implications for HIV-associated nephropathy (abstract). Clin Res 39: 219A, 1991.Google Scholar
  153. 153.
    Shukla RR, Kumar A, Kimmel PL: Transforming growth factor beta increases the expression of HIV-1 gene in human mesangial cells. Kidney Int 44: 1022–1029, 1993.PubMedCrossRefGoogle Scholar
  154. 154.
    Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T: Viral DNA in microdissected renal tissue biopsy from HIV infected patients with nephotic syndrome. Kidney Int 43: 1347 1352, 1993.Google Scholar
  155. 155.
    Alpers CE, Baskin GB: Sclerosing glomerulopathy in rhesus monkeys with simian AIDS (abstract). Kidney Int 35: 339, 1989.Google Scholar
  156. 156.
    Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109–119, 1991.PubMedCrossRefGoogle Scholar
  157. 157.
    Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci USA 89: 1577–1581, 1992.PubMedCrossRefGoogle Scholar
  158. 158.
    Kopp JB, McCune BK, Notkins AL, Sporn MB, Klotman PE: Increased expression of transforming growth factor beta in HIV-transgenic mouse kidney (abstract). J Am Soc Nephrol 1: 600, 1991.Google Scholar
  159. 159.
    Bruggeman LA, Adler SH, Rappaport J, Klotman PE: Role of NF-Kb in the renal expression of HIV-1 transgenic mice (abstract). J Am Soc Nephrol 4: 596, 1993.Google Scholar
  160. 160.
    Bauer FA, Wear DJ, Angritt P, Lo SC: Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study. Human Pathol 22: 63–69, 1991.CrossRefGoogle Scholar
  161. 161.
    Cohen AH: Mycoplasmal infection in the kidneys of patients with acquired immunodefficiency syndrome (letter). Hum Pathol 22: 932–933, 1991.PubMedCrossRefGoogle Scholar
  162. 162.
    Foster S, Hawkins E, Hanson CG, Shearer W: Pathology of the kidney in childhood immunodeficiency: AIDS-related nephropathy is not unique. Pediatr Pathol 11: 63–74, 1991.PubMedCrossRefGoogle Scholar
  163. 163.
    Wolthuis A, van Goor H, Weening JJ, Grond J: Pathobiology of focal sclerosis. Curr Opin Nephrol Hypertens 2: 458–464, 1993.PubMedCrossRefGoogle Scholar
  164. 164.
    Szabolcs MJ, Inghirami G, Liv J, Ward L, D’Agati V: Analysis of cellular proliferation in human glomerulopathies using ki-67 and PCNA (abstract). J Am Soc Nephrol 4: 690, 1993.Google Scholar
  165. 165.
    Bodi I, Abraham A, Kimmel PL: Macrophages in immunodeficiency-virus associated kidney disease. Am J Kidney Dis 24: 762–767, 1994.PubMedGoogle Scholar
  166. 166.
    Ahukla RR, Kimmel PL, Kunar A: Molecular Biology of HIV-1 and Kidney disease. In: P. Kimmel, J. Stein, eds, Conterporary Issues in Nephrology, Churchill Livingstone, New York, 29:329–379, 1996.Google Scholar
  167. 167.
    Bodi I, Kimmel PL, Abraham A, Sporn MB, Klotman PE, Kopp JB: Increased TGF-13 expression in human HIV-associated nephropathy (abstract). J Am Soc Nephrol 4: 461, 1993.Google Scholar
  168. 168.
    Border W, Yamamoto T, Noble N, Gold L, Nast C, Cohen A: HIV-associated nephropathy is linked to TGF-(• and matrix protein expression in human kidney (abstract). J Am Soc Nephrol 4: 675, 1993.Google Scholar
  169. 169.
    Mattana J, Abramovici M, Singhal PC: Effects of human immunodeficiency virus sera and macrophage supernatants on mesangial cell proliferation and matrix synthesis. Am J Clin Pathol 143: 814–822, 1993.Google Scholar
  170. 170.
    Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A: Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr 119: 710–716, 1991.PubMedCrossRefGoogle Scholar
  171. 171.
    Strauss J, Abitbol C, Zilleruelo G, Scott G, Paredes A, Malaga S, Montane B, Mitchell C, Parks W, Pardo V: Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 321: 625–6630, 1989.PubMedCrossRefGoogle Scholar
  172. 172.
    Smith MC, Carey JT, Jacobs GH, Kalayian RC, Menon A, Pawar R, Salata RA, Seliga R: Corticosteroid therapy ameliorates the progression of human immunodeficiency virus associated nephropathy (abstract). J Am Soc Nephrol 4: 287, 1993.Google Scholar
  173. 173.
    Babut-Gay ML, Echard M, Kleinknecht D, Meyrier A: Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection (letter). Ann Intern Med 111: 856–857, 1989.PubMedCrossRefGoogle Scholar
  174. 174.
    Cook PP, Appel RG: Prolonged clinical improvement in HIV-associated nephropathy with zidovudine therapy (abstract). J Am Soc Nephrol 1: 842, 1990.PubMedGoogle Scholar
  175. 175.
    Lam M, Park MC: HIV-associated nephropathy: beneficial effect of zidovudine therapy (letter). N Engl J Med 323: 1775 1776, 1990.Google Scholar
  176. 176.
    Harrer T, Hunzelmann N, Stoll R, Baur A, Kalden JR: Therapy for HIV-1 related nephritis with zidovudine. AIDS 4: 815–817, 1990.PubMedCrossRefGoogle Scholar
  177. 177.
    Rao TKS, Friedman EA: A decade of human immunodeficiency associated nephropathy (abstract). J Am Soc Nephrol 4: 284, 1993.Google Scholar
  178. 178.
    Ifudu O, Rao TKS, Tan CC, Fleishman H, Chirgwin K, Friedman EA: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 15: 217–221, 1995.PubMedCrossRefGoogle Scholar
  179. 179.
    Ahmed V, Kloser P, Miller MA, Lasker N: Does zidovudine slow the progression of HIV nephropathy? (abstract). J Am Soc Nephrol 4: 269, 1993.Google Scholar
  180. 180.
    Neuzil KM: Pharmacologic therapy of human immunodeficiency virus infection: a review. Am J Med Sci 307: 368–373, 1994.PubMedCrossRefGoogle Scholar
  181. 181.
    Burns GC, Matute R, Onyema D, Davis I, Toth I: Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: a case report. Am J Kidney Dis 23: 441–443, 1994.PubMedGoogle Scholar
  182. 182.
    Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ: Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int 34: 248–253, 1988.PubMedCrossRefGoogle Scholar
  183. 183.
    Ortiz-Interian C, Acosta D: Long term (5 year) survival on maintenance hemodialysis is possible for patients infected with the human immunodeficiency virus (abstract). Clin Res 39: 222A, 1991.Google Scholar
  184. 184.
    Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP: Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with enstage renal disease. Kidney Int 44: 373–378, 1993.PubMedCrossRefGoogle Scholar
  185. 185.
    Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO: Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 44: 19 1198, 1993.Google Scholar
  186. 186.
    Schoenfeld P: Renal disease and HIV infection: clinical course, treatment outcome, and infection control. Am Nephrol Nursing Assoc J 17: 21–28, 1990.Google Scholar
  187. 187.
    Breyer JA, Harbison MA: Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 21: 23–25, 1993.PubMedGoogle Scholar
  188. 188.
    Schoenfeld P, Feduska NJ: Acquired immunodeficiency syndrome and renal disease: report of the National Kidney Foundation-National Institutes of Health task force on AIDS and kidney disease. Am J Kidney Dis 16: 14–25, 1990.PubMedGoogle Scholar
  189. 189.
    Pennell JP, Bourgoignie JJ: Should AIDS patients be dialyzed? Trans Am Soc Artif Intern Organs 34: 907–911, 1988.Google Scholar
  190. 190.
    Appel RG, Neill J: A steroid-responsive nephrotic syndrome in a patient with human immunodeficiency virus (HIV) infection. Ann Intern Med 113: 892–893, 1990.PubMedCrossRefGoogle Scholar
  191. 191.
    Guerra IL, Abraham AA, Kimmel PL, Sabnis SS, Antonovych TT: Nephrotic syndrome associated with chronic persistent hepatitis B in an HIV antibody positive patient. Am J Kidney Dis 10: 385–388, 1987.PubMedGoogle Scholar
  192. 192.
    Collins AB, Khan AK, Dienstag H, Colvin RB, Haupert GT Jr, Mushawar IK, McCluskey RT: Hepatitis B immune-complex glomerulonephritis. Simultaneous glomerular deposits of hepatitis B surface and e antigens. Clin Immunol Immunopathol 28: 137–153, 1983.CrossRefGoogle Scholar
  193. 193.
    Schectman JM, Kimmel PL: Remission of hepatitis B-associated membranous glomerulonephritis in human immunodeficiency virus infection. J Kidney Dis 17: 716–718, 1991.Google Scholar
  194. 194.
    Kusner DJ, Ellner JJ: Syphilis, a reversible cause of nephrotic syndrome in HIV infection (letter). N Engl J Med 324: 34 1342, 1991.Google Scholar
  195. 195.
    D’Agati V, Seigle R: Coexistence of AIDS and lupus nephritis: a case report. Am J Nephrol 10: 243–247, 1990PubMedCrossRefGoogle Scholar
  196. 196.
    Bourgoignie JJ, Pardo V: Human immunodeficiency virusassociated nephropathies (editorial). N Engl J Med 327: 729–730, 1992.PubMedCrossRefGoogle Scholar
  197. 197.
    Jackson S, Dawson LM, Kotler DP: IgA 1 is the major immunoglobulin component of immune complexes in the acquired immunodeficiency syndrome. J Clin Immunol 8: 64–68, 1988.PubMedCrossRefGoogle Scholar
  198. 198.
    Jackson S, Tarkowski A, Collins JE, Dawson LM, Schrohenloher RE, Kotler DP, Koopman WJ: Occurrence of polymeric IgAl rheumatoid factor in the acquired immunodeficiency syndrome. J Clin Immunol 8: 390–396, 1988PubMedCrossRefGoogle Scholar
  199. 199.
    Jackson S: Immunoglobulin-antiimmunoglobulin interactions and immune conplexes in IgA nephropathy. Am J Kidney Dis 12: 425–429, 1988.PubMedGoogle Scholar
  200. 200.
    Béné MC, Canton P, Amiel C, May T, Faure G: Absence of mesangial IgA in AIDS: a postmortem study. Nephron 58: 240–241, 1991.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Jacques J. Bourgoignie
    • 1
  1. 1.Division of Nephrology (R-126)University of Miami School of MedicineMiamiUSA

Personalised recommendations